首页> 外文期刊>Nature Genetics >No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas
【24h】

No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas

机译:没有证据表明人类乳腺癌和卵巢癌的癌症相关成纤维细胞具有克隆性的体细胞遗传学改变

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

There is increasing evidence showing that the stromal cells surrounding cancer epithelial cells, rather than being passive bystanders, might have a role in modifying tumor outgrowth. The molecular basis of this aspect of carcinoma etiology is controversial. Some studies have reported a high frequency of genetic aberrations in carcinoma-associated fibroblasts (CAFs), whereas other studies have reported very low or zero mutation rates. Resolution of this contentious area is of critical importance in terms of understanding both the basic biology of cancer as well as the potential clinical implications of CAF somatic alterations. We undertook genome-wide copy number and loss of heterozygosity (LOH) analysis of CAFs derived from breast and ovarian carcinomas using a 500K SNP array platform. Our data show conclusively that LOH and copy number alterations are extremely rare in CAFs and cannot be the basis of the carcinoma-promoting phenotypes of breast and ovarian CAFs.
机译:越来越多的证据表明,癌上皮细胞周围的基质细胞,而不是被动的旁观者,可能在改变肿瘤的生长中起作用。癌症病因的这一方面的分子基础是有争议的。一些研究报告了与癌相关的成纤维细胞(CAF)的遗传畸变的频率很高,而其他研究则报告了非常低或零的突变率。就理解癌症的基本生物学以及CAF体细胞改变的潜在临床意义而言,解决这一有争议的领域至关重要。我们使用500K SNP阵列平台对源自乳腺癌和卵巢癌的CAF进行了全基因组拷贝数和杂合度丢失(LOH)分析。我们的数据最终表明,LOH和拷贝数变化在CAF中极为罕见,并且不能作为乳腺癌和卵巢CAF的促癌表型的基础。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号